Evidence map›Paper›PMID 42147920›Full record

ArticleQuantitative imaging in medicine and surgery2026

Evaluation of

Yi Zhou, Dan Cao, Neng-Wen Ke, Rong Tian, Ming-Gang Su

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yi ZhouDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Dan CaoDivision of Abdominal Tumor, Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Neng-Wen KeDivision of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Rong TianDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Ming-Gang SuDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The clinical management of small (<20 mm), nonfunctional, nonmetastatic pancreatic neuroendocrine neoplasms (panNENs) relies heavily on accurate pathological grading, as Grade 1 (G1) tumors are often managed with active surveillance, whereas Grade 2 (G2) tumors warrant surgical resection. Currently, limited biopsy sampling may misrepresent the true tumor grade due to intratumoral heterogeneity, and conventional imaging lacks grading accuracy. Although Methods: A retrospective study was conducted between January 2019 and January 2025 on patients with histologically confirmed panNENs. All 34 patients (with 41 lesions) underwent Results: No significant differences in G-SUV or the G-SUV/F-SUV ratio were found between G1 and G2 (P=0.355 and P=0.861, respectively). In contrast, F-SUV was significantly lower in G1 than in G2 (P=0.003), with an optimal cutoff value of 2.5, yielding a sensitivity of 73% and a specificity of 89%. Although visual assessment of neither Conclusions:

Indexed as

18F-fluorodeoxyglucose (18F-FDG)68Ga-DOTA0-Tyr3-octreotate (68Ga-DOTATATE)gradingKi67Pancreatic neuroendocrine neoplasm (panNEN)

Identifiers

PMID42147920
PMCPMC13178343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.